𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A study of the serum properdin levels of patients with malignant tumors

✍ Scribed by Antonio Rottino; Arthur L. Levy; Alexander Conte

Publisher
John Wiley and Sons
Year
1958
Tongue
English
Weight
444 KB
Volume
11
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Increase of serum complement levels in c
Increase of serum complement levels in cancer patients with progressing tumors
✍ Herman Verhaegen; Walter De Cock; Jean De Cree; Frank Verbruggen πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 396 KB πŸ‘ 2 views

Complement levels (CH,,, C,, C, and C1,) were determined in sera of 90 healthy subjects and 200 cancer patients. Complement levels of cancer patients were significantly higher than those of the healthy subjects, but there was a stagelinked increase of complement levels. Patients in remission had nea

Serum levels of soluble tumor-necrosis-f
Serum levels of soluble tumor-necrosis-factor receptors in patients with benign and malignant HPV-associated anogenital lesions
✍ Magdalena Malejczyk; Jaroslaw JΓ³ΕΊwiak; Anna Osiecka; Piotr I. Roszkowski; Walent πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 83 KB πŸ‘ 2 views

The levels of type-I and type-II soluble TNF-␣ receptors (sTNF-Rs) were evaluated in sera from patients with various human-papillomavirus-(HPV)-associated benign and malignant anogenital lesions using specific enzyme-linked immunobiological assays. In patients with benign HPV6/11-associated condylom

Liver embolizations of patients with mal
Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors
✍ B. K. Eriksson; E. G. Larsson; B. M. Skogseid; A. M. LΓΆfberg; L. E. LΓΆrelius; K. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

## BACKGROUND. Patients with neuroendocrine gastrointestinal tumors usually present with inoperable metastatic disease and severe hormonal symptoms. Specific chemotherapy, interferon-␣ (IFN), and somatostatin analogs are established therapies for these patients, but all of them eventually fail. Hep